ARCHIVES

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

This article is from The Cancer Letter archive.

Vol. 35 No. 28 | July 17, 2009

Download PDF Visit The Full Archive

Related Articles

St. Jude Begins $100 Million Expansion Program

December 4, 1987

New Jersey Center To Have Two Alliances: One With CINJ—and One With MD Anderson

June 21, 2013

FDA Warns of Lymphoma Risk Associated With Breast Implants

January 28, 2011

In Congress: Conferees Approve 42 billion Increase For NIH Appropriations

October 29, 1999

NCI Cancer Education Program To Open To Innovative Ideas

April 2, 1993

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014